Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113550 | Critical Reviews in Oncology/Hematology | 2016 | 8 Pages |
Abstract
This meta-analysis suggests both KRAS and BRAF mutations as poor, prognostic biomarkers, associated with worse survival outcomes, in patients undergoing hepatic resection of CLM.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Francesco Passiglia, Giuseppe Bronte, Viviana Bazan, Antonio Galvano, Bruno Vincenzi, Antonio Russo,